SCHEMBL29610334

SCHEMBL29610334

O=C1Nc2ccnc3cccc1c23

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.46
CYP1A2 P05177 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
PDGFRA P16234 1/20 0.41
FER P16591 1/20 0.41
LTK P29376 1/20 0.41
CDK8 P49336 1/20 0.41
ACVR1 Q04771 1/20 0.41
LRRK2 Q5S007 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
CDK5 Q00535 2/20 0.40
CDK5R1 Q15078 1/20 0.40
ALDH1A1 P00352 8/20 0.40
KDM4E B2RXH2 6/20 0.40
HSD17B10 Q99714 5/20 0.40
CASP1 P29466 5/20 0.40
CASP7 P55210 5/20 0.40
HPGD P15428 4/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
ALOX15 P16050 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25302389 0.93 CYP1A2 (0.45) PARP1CYP1A2SMN1; SMN2PDGFRAFER
SCHEMBL29029657 0.85 PARP1 (0.53) PARP1CYP1A2SMN1; SMN2ACVR1CASP1
SCHEMBL421641 0.75 AHR (0.54) CYP1A2PDGFRAFERLTKCDK8
SCHEMBL29428940 0.71 PARP1 (0.72) PARP1PDGFRAFERLTKCDK8
SCHEMBL302763 0.71 PARP1 (0.72) PARP1PDGFRAFERLTKCDK8
SCHEMBL30530523 0.70 CDK5 (0.42) PARP1CYP1A2SMN1; SMN2PDGFRAFER
SCHEMBL24330117 0.70 CDK5 (0.42) PARP1CYP1A2SMN1; SMN2PDGFRAFER
SCHEMBL24316070 0.70 CCR1 (0.40) PARP1CYP1A2SMN1; SMN2PDGFRAFER
SCHEMBL24316072 0.69 CYP1A2 (0.33) CYP1A2SMN1; SMN2ALDH1A1HSD17B10ALOX15
SCHEMBL24315814 0.69 PARP1 (0.36) PARP1CYP1A2SMN1; SMN2PDGFRAFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228639-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed